Search Results for 'license'
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials
Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany
Covers the combination of DHODH inhibitors and nucleoside analogues to treat viral infections, including Covid-19.09.22.21
-
Biologics, Proteins, Vaccines | Breaking News
Nobelpharma Signs License Agreement to Use ProBioGen’s Vaccine Production Platform
The cell-based system for vaccine production offers a cost-effective, efficient and flexible alternative to traditional vaccine production.08.12.21
-
Breaking News | cGMP Manufacture | Industry News
WuXi Biologics Receives Manufacturing License from German Health Authorities
The inspections comprised areas of cGMP manufacturing required for receiving the permit, as well as commercial production approval.07.26.21
-
Breaking News | Facilities | Industry News
SpectronRx Receives Nuclear Materials License for New Indiana Facility
Indiana-based radiopharmaceutical CDMO expands nuclear pharmacy capabilities with second location.07.22.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Intravacc's Inactivated Polio Vaccine Out-licensed to Sinovac
Sinovac's Eupolio vaccine (sIPV) receives market authorization from the NMPA in China.07.20.21
-
Breaking News | Collaborations & Alliances
Bicycle Therapeutics, Ionic Pharma Enter License & Collaboration Agreement
Will work together to develop targeted oligonucleotide therapeutics leveraging tissue-targeting TfR1 Bicycle technology.07.13.21
-
Breaking News | Collaborations & Alliances | Industry News
Innovent Biologics Signs License Agreement with Synaffix
Synaffix will provide proprietary ADC technologies to enable Innovent to rapidly progress one of its antibodies as a best-in-class ADC candidate.07.01.21
-
APIs | Breaking News | cGMP Manufacture | Industry News
Onyx Scientific Receives Commercial API License for UK Facility
Allows Onyx to support API projects from pre-clinical studies to low volume commercial manufacture.Charles Sternberg, Assistant Editor 06.03.21
-
Breaking News | Collaborations & Alliances | Industry News
Elektrofi, Argenx Enter Collaboration and License Agreement
Will explore new subcutaneous formulations for therapeutic products directed at the human neonatal Fc receptor.Charles Sternberg, Assistant Editor 04.27.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Scale-up/Technology Transfer
SpyBiotech Licenses Selexis’ SUREtechnology for HCMV Vax
Will leverage SUREtechnology Platform to generate stable, high-yield production cell lines needed for human clinical trials.Kristin Brooks 03.18.21
-
APIs | Breaking News | Formulation Development | Industry News
Tris Pharma, Athena Bioscience Enter Exclusive License Agreement
Athena gains exclusive rights to commercialize a long-acting antihypertensive product developed using Tris' proprietary technology.Kristin Brooks 02.22.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
AbbVie Licenses ProBioGen’s GlymaxX Technology
Will apply GlymaxX technology to boost the antibody-dependent cell-mediated cytotoxicity (ADCC).Kristin Brooks 01.22.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Biogen Licenses CEVEC AAV Mfg. Technology
Biogen gains rights to ELEVECTA Technology for manufacturing of gene therapy products.Contract Pharma Staff 01.08.21
-
Breaking News | Collaborations & Alliances | Industry News
Lead Pharma and Roche Enter Collaboration & License Agreement
Will develop oral small molecules to treat immune mediated diseases.Contract Pharma Staff 11.16.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
CEVEC, Roche Ink ELEVECTA Technology License Agreement
Allows Roche to use CEVEC's ELEVECT Technology for AAV vector manufacturing for its portfolio of gene therapy products.Contract Pharma Staff 11.11.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
CEVEC, Rznomics Ink License Agreement for CAP Technology
Rznomics will use CEVEC’s cell line technology with its trans-splicing ribozyme technology for manufacturing gene therapies targeting various cancers.10.20.20
-
Breaking News | Collaborations & Alliances | Drug Development
Sperogenix and Minoryx Enter Exclusive License Agreement
Will develop and commercialize leriglitazone in mainland China, Hong Kong and Macau.Contract Pharma Staff 09.23.20
-
Breaking News | Clinical Trials
Rain Therapeutics Licenses MDM2 Inhibitor from Daiichi Sankyo
DS-3032 has been evaluated in clinical trials for solid tumors and hematologic malignancies.Contract Pharma Staff 09.02.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
iBio Signs License Agreement with Planet Biotechnology for COVID-19 Therapeutic
ACE2-Fc directly targets coronavirus virions.Contract Pharma Staff 09.01.20
-
Breaking News | Drug Development | Industry News
Ovid, Angelini Pharma Enter Exclusive License Agreement
To develop, manufacture and commercialize OV101 for the treatment of Angelman Syndrome in EuropeContract Pharma Staff 07.13.20
-
Breaking News | Drug Development | Industry News
Oncology Venture Out-Licenses Clinical Assets to Smerud
Smerud will advance development of LiPlaCis in late stage metastatic breast cancer and 2X-111 in glioblastoma multiforme.Contract Pharma Staff 06.29.20
-
Breaking News | Collaborations & Alliances | Drug Development
Neurocrine Licenses Seven Takeda Compounds in $2B Deal
To develop and commercialize early-to-mid-stage psychiatry pipeline including assets for for schizophrenia, treatment-resistant depression and anhedonia.Contract Pharma Staff 06.19.20
-
Breaking News | Industry News
Wasdell Group Receives IMP License for European HQ
Enables Wasdell to expand the facility’s services.Contract Pharma Staff 05.29.20
-
Formulation Development | Industry News
SeraNovo, Carna Biosciences Enter Second License Agreement
To develop an oral formulation of a new active ingredient with enhanced bioavailability.Contract Pharma Staff 05.26.20
-
Breaking News | Industry News
Gilead, Mylan Ink Global Remdesivir License Agreement
To supply Remdesivir for potential COVID-19 treatment in 127 low- and middle-income countries.Contract Pharma Staff 05.12.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News
Fujifilm Diosynth Licenses Oxgene's AAV system
Aims to deliver gene therapy products to clients with an approximate 25% lead-time reductionContract Pharma Staff 04.23.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
panCELLa, CCRM Collaborate to Benefit Academia and Industry
New iPSC master cell banks to accelerate development of novel cell therapiesContract Pharma Staff 04.21.20
-
Breaking News | Collaborations & Alliances | Drug Delivery | Industry News | Injectables
Micropore, InnoCore Enter Injectable Drugs Collaboration
Will deploy encapsulation technology in the production of a new generation of long acting injectablesContract Pharma Staff 04.21.20
-
New iPSC Master Cell Banks to Accelerate Development of Novel Cell Therapies
panCELLa and CCRM collaborate to benefit academia and industry
-
Breaking News | Promotions & Moves
ADC Therapeutics Appoints Jennifer Creel as CFO
Former Celgene executive brings deep oncology-focused financial expertiseContract Pharma Staff 04.21.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Soligenix Licenses BTG’s CoVaccine HT for SARS-CoV-2
Novel adjuvant has been shown to enhance both cell-mediated and antibody-mediated immunityContract Pharma Staff 04.16.20
-
Breaking News | Drug Development | Trials & Filings
Regeneron's BLA for Ebola Cocktail Gets Priority Review
VelociSuite technologies facilitate rapid generation of optimized antibodies allowing for cell line production and large-scale bioreactor manufacturingContract Pharma Staff 04.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
AIkido Pharma Inks Exclusive License for Antiviral Drug Platform
Pan-viral inhibitory compound with efficacy against multiple viral pathogens including Influenza, SARS-COV, MERS-COV, Ebola and Marburg virusContract Pharma Satff 04.14.20
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Arrakis, Roche Ink Multi-Billion Dollar Deal to Develop RNA-based Therapies
Multi-target program to utilize RNA-targeted small molecule drug discovery platformContract Pharma Staff 04.09.20
-
Breaking News | Collaborations & Alliances | Drug Development
Amgen, Adaptive Biotech Enter COVID-19 Antibody Alliance
Aims to accelerate the development of a potential antibody against COVID-19 as fast as possible04.02.20
-
Breaking News | Collaborations & Alliances | Industry News
Citius, Novellus Ink COVID-19 Pact
Citius to license novel stem-cell therapy for acute respiratory distress syndrome (ARDS) associated with COVID-1904.01.20
-
Breaking News | Collaborations & Alliances | Drug Development
I-Mab, Kalbe Genexine Enter Strategic Pact
KG Bio will have option for exclusive rights to commercialize two I-Mab product candidates.03.31.20
-
Breaking News | Collaborations & Alliances | Drug Development
Lilly, Sitryx Enter Autoimmune Alliance
To develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation.03.31.20
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
Alvotech, DKSH Partner to Bring Biosimilar to Asia
Biosimilar of AbbVie’s Humira to be developed and supplied by Alvotech03.26.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development
Akers Biosciences Licenses Premas Coronavirus Vax Candidate
Aims to accelerate development timeline leveraging the D-Crypt platform03.25.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Debiopharm Expands Its Radiopharmaceutical Footprint
Exclusive license and research agreement to further develop radioligand program to fight the progression of cancer.03.25.20
-
Breaking News | Collaborations & Alliances | Drug Development
Forge, Roche Enter Antibiotic Alliance
To develop novel antibiotic to treat serious lung infections attributed to antibiotic-resistant Gram-negative bacteria03.25.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Codexis, Takeda Sign Gene Therapy Collaboration
Partnership to leverage Codexis’ protein engineering platform to advance novel gene therapies for rare genetic disorders03.24.20
-
-
Breaking News | Collaborations & Alliances | Drug Delivery | Industry News
Hikma, Glenmark Enter Nasal Spray Tie-up
Builds on Hikma's leading position in nasal sprays02.28.20
-
Analytical Services | Breaking News | Industry News | Laboratory Testing
Pluton Biosciences Acquires Microbe Inotech Labs
MiL’s pathogen testing provides Pluton a foundation to build out Micro-mining microbial discovery platform02.20.20
-
Breaking News | Facilities | Industry News
Vetio Awarded Cannabis Research License from Health Canada
Begins development of cannabis-based veterinary drug products in Montreal02.19.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Excipients | Industry News
ReForm Biologics, MilliporeSigma Enter Excipient Agreement
Deal covers excipient development and commercialization02.10.20
-
Breaking News | Industry News | Inspections
-
Breaking News | Collaborations & Alliances | Drug Development
Avacta, Daewoong Partner with AffyXell Therapeutics
To utilize Affimer proteins in next generation cell and gene therapies02.03.20
